Negara: Kanada
Bahasa: Inggris
Sumber: Health Canada
ROCURONIUM BROMIDE
EUGIA PHARMA INC.
M03AC09
ROCURONIUM BROMIDE
10MG
SOLUTION
ROCURONIUM BROMIDE 10MG
INTRAVENOUS
100
Prescription
Active ingredient group (AIG) number: 0126317001; AHFS:
APPROVED
2022-07-08
Page 1 of 35 PRODUCT MONOGRAPH PR ROCURONIUM BROMIDE INJECTION 10 mg/mL Solution for Injection (50 mg/5 mL and 100 mg/10 mL) Sterile Solution Non-depolarizing Skeletal Neuromuscular Blocking Agent EUGIA PHARMA INC. 3700 Steeles Avenue West, Suite # 402 Woodbridge, Ontario L4L 8K8, Canada Submission Control No.: 264657 Date of Preparation: July 7, 2022 Page 2 of 35 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ................................................................ 3 SUMMARY PRODUCT INFORMATION ...................................................................................... 3 INDICATIONS AND CLINICAL USE ............................................................................................ 3 CONTRAINDICATIONS ................................................................................................................. 4 WARNINGS AND PRECAUTIONS ................................................................................................ 4 ADVERSE REACTIONS .................................................................................................................. 8 DRUG INTERACTIONS ................................................................................................................ 11 DOSAGE AND ADMINISTRATION ............................................................................................ 12 OVERDOSAGE .............................................................................................................................. 18 ACTION AND CLINICAL PHARMACOLOGY........................................................................... 18 STORAGE AND STABILITY ........................................................................................................ 25 SPECIAL HANDLING INSTRUCTIONS ..................................................................................... 26 DOSAGE FORMS, COMPOSITION AND PACKAGING ........................................................... 26 PART II: SCIENTIFIC INFORMATION .............................. Baca dokumen lengkapnya